NN0519-0130という薬剤の異なる投与量が2型糖尿病患者の血糖値をどの程度下げるかを比較した研究

基本情報

NCT ID

NCT06326047

ステータス

完了

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

299

治験依頼者名

Novo Nordisk A/S

概要

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-0130. Which treatment participant will get is decided by chance. Participants will take 1-3 injections once a week. The study medicine will be injected under skin with a thin needle in the stomach, thigh, or upper arm. The study will last for about 40 weeks.

対象疾患

介入

依頼者（Sponsor）

実施施設 (4)